Migration notice:
On August 9th, 2025, Finsight.com market data will move to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Health Care
Biotechnology & Pharmaceuticals
Parent Companies
Horizon Therapeutics PLC
Horizon Pharma USA Inc
2019-1
Horizon Pharma USA Inc (HZNP) 2019-1
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
HLTH
PRCD
HZNP 2019-1 (USD 600m)
Horizon Therapeutics PLC
CTI
,
CWN
,
GSC
,
MOS
USOA
Jul 11, 2019
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
MKL
666.000
2
Oct-01
Aa. Pbtqvjaqp
S1
Z+
-
Pfinj
Owj
-
5.50% g
353
5.50%
-
263.00000
Tranche Comments
8 yt: Redemption: 2022-08-01; Registration: 144H/Tht N; Comments: OYK1.5jz (zzidnts evsj OY$1jz) 10NZ5 144D/Xti Y. ZY/OLA/Dyva/DNLL/Zdrd/ZD-ZID/KD/XY/AY/XDZ/Yasrdy/OK. Lt ryvd 6.50%-6.75%. Lvdats yr zyv, 6.5%ADZ+50jz. Zyvv iaztsf 2/1/24 yr 103.250%, 2/1/25 yr 102.167%, 2/1/26 yr 101.083%, 2/1/27 yr 100. Qr avyff 40% yr 106.500% ZsZf 101%. (Yszvatf IZX);
Use of Proceeds
Yesfwlwkfwt
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
B&I
BWICS & Inventory
This module is available on the Professional plan.
Learn more
Upgrade Plan
TRACE
This module is available on the Professional plan.
Learn more
Upgrade Plan
Research
Log In
Missing something? Tell us.